CorMedix (CRMD) Free Cash Flow Growth (5y) (2015 - 2025)
CorMedix (CRMD) Free Cash Flow Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.65 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.09 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - |
| 8 | Argenx Se | 55.74 Bn | 50.56 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - |
| 10 | CorMedix | 4.95 Mn | -150.26 Mn | 107.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 77.12% |
| Sep 30, 2025 | 43.75% |
| Jun 30, 2025 | 110.69% |
| Mar 31, 2025 | 34.93% |
| Dec 31, 2024 | -7.63% |
| Sep 30, 2024 | -28.04% |
| Jun 30, 2024 | -145.65% |
| Mar 31, 2024 | -18.65% |
| Dec 31, 2023 | -8.93% |
| Sep 30, 2023 | -11.20% |
| Jun 30, 2023 | -14.62% |
| Mar 31, 2023 | -7.97% |
| Dec 31, 2022 | 3.22% |
| Sep 30, 2022 | 2.31% |
| Jun 30, 2022 | 6.73% |
| Mar 31, 2022 | 0.04% |
| Dec 31, 2021 | 0.01% |
| Sep 30, 2021 | 0.99% |
| Jun 30, 2021 | 3.85% |
| Mar 31, 2021 | -4.23% |